Results 231 to 240 of about 78,018 (293)
Immunophenotypic abnormality quantification refines multiparameter flow cytometry-based measurable residual disease testing in adults allografted for acute myeloid leukemia in morphologic remission. [PDF]
Le CM +8 more
europepmc +1 more source
ABSTRACT Introduction and Methods Cancer therapy–related cardiac dysfunction (CTRCD) is a well established and potentially life‐threatening complication of contemporary oncologic treatment. Although comprehensive cardio‐oncology guidelines have been developed, their integration into routine hematology and oncology practice remains inconsistent.
Abdelrahman Ali +22 more
wiley +1 more source
Clinical factors associated with venous thromboembolism in multiple myeloma patients treated with daratumumab. [PDF]
Subramanian NG +8 more
europepmc +1 more source
Brachymetatarsia as an Early Clue to Turner Syndrome
ABSTRACT Congenital anomalies of the extremities, particularly bilateral toe or finger malformations, may provide an early and valuable clue to an underlying genetic disorder and should prompt further diagnostic evaluation. Brachymetatarsia is a rare associated finding that may raise suspicion for Turner syndrome, particularly when diagnosis is delayed
Hounaida Mahfoud, Zaki Elhanchi
wiley +1 more source
P140: A rare phenomenon: Double trisomy rescue detected during clinical SNP microarray testing*
Andrea Penton +4 more
doaj +1 more source
A left basal ganglia lesion in a 57-year-old patient. [PDF]
Atiya S +3 more
europepmc +1 more source
Down Syndrome due to de Novo Robertsonian Translocation Rob(21;21) in Mali
ABSTRACT Down syndrome (DS) is the most common chromosomal disorder among live births, most frequently resulting from free trisomy 21. Robertsonian translocations, which arise from the fusion of acrocentric chromosomes, represent a rare but clinically significant mechanism underlying DS.
Christine Ongoiba +6 more
wiley +1 more source
Outcomes of therapy-related non-core binding factor acute myeloid leukemia with venetoclax-based therapies. [PDF]
Senapati J +21 more
europepmc +1 more source

